Sven Dethlefs, EVP, North America Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 4,862 shares at $8.14 ($40K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Scheduled sale ($40k) by EVP, North America Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2022-03-08 | $132K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $37K | — | Filing → |
| TEVA | SELL | 2021-03-08 | $127K | — | Filing → |